These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18426893)

  • 21. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia.
    Rijneveld AW; Florquin S; Hartung T; Speelman P; van der Poll T
    J Infect Dis; 2003 Jul; 188(2):282-5. PubMed ID: 12854084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
    Zervos M; Mandell LA; Vrooman PS; Andrews CP; McIvor A; Abdulla RH; de Caprariis PJ; Knirsch CA; Amsden GW; Niederman MS; Lode H
    Treat Respir Med; 2004; 3(5):329-36. PubMed ID: 15606222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia.
    Wang E; Bergeron Y; Bergeron MG
    J Antimicrob Chemother; 2005 May; 55(5):721-6. PubMed ID: 15772139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis.
    Messmann H; Vogt W; Falk W; Vogl D; Zirngibl H; Leser HG; Schölmerich J
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):611-7. PubMed ID: 9855088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro effects of fluoroquinolones on lipopolysaccharide-induced pro-inflammatory cytokine production.
    Ogino H; Fujii M; Ono M; Maezawa K; Hori S; Kizu J
    J Infect Chemother; 2009 Jun; 15(3):168-73. PubMed ID: 19554401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of anaesthesia and surgery on plasma cytokine production.
    Helmy SA; Wahby MA; El-Nawaway M
    Anaesthesia; 1999 Aug; 54(8):733-8. PubMed ID: 10460524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.
    Wang E; Simard M; Ouellet N; Bergeron Y; Beauchamp D; Bergeron MG
    J Infect Dis; 2000 Oct; 182(4):1255-9. PubMed ID: 10979929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia.
    de Porto AP; Liu Z; de Beer R; Florquin S; de Boer OJ; Hendriks RW; van der Poll T; de Vos AF
    Mol Med; 2019 Jan; 25(1):3. PubMed ID: 30646846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials.
    Fogarty CM; Greenberg RN; Dunbar L; Player R; Marrie TJ; Kojak CM; Morgan N; Williams RR
    Clin Ther; 2001 Mar; 23(3):425-39. PubMed ID: 11318077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.
    Fernández-Serrano S; Dorca J; Coromines M; Carratalà J; Gudiol F; Manresa F
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):813-20. PubMed ID: 12965910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae.
    Seok H; Kang CI; Huh K; Cho SY; Ha YE; Chung DR; Peck KR
    Microb Drug Resist; 2018 Nov; 24(9):1412-1416. PubMed ID: 29565225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
    Naba MR; Araj GF; Baban TA; Tabbarah ZA; Awar GN; Kanj SS
    J Infect Public Health; 2010; 3(3):113-7. PubMed ID: 20869671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic cytokine response in patients with community-acquired pneumonia.
    Endeman H; Meijvis SC; Rijkers GT; van Velzen-Blad H; van Moorsel CH; Grutters JC; Biesma DH
    Eur Respir J; 2011 Jun; 37(6):1431-8. PubMed ID: 20884746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.
    Clark LC; Davis CW
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls.
    Bauer TT; Montón C; Torres A; Cabello H; Fillela X; Maldonado A; Nicolás JM; Zavala E
    Thorax; 2000 Jan; 55(1):46-52. PubMed ID: 10607801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
    Fogarty C; Goldschmidt R; Bush K
    Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in mice.
    Bast DJ; Dresser L; Duncan CL; Walker SE; Mandell LA; Low DE; de Azavedo JC
    J Chemother; 2006 Dec; 18(6):634-40. PubMed ID: 17267342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.